LYMPHOMA

This is an early safety study for people with advanced lymphoma, myeloma, or certain solid tumors (like kidney cancer and sarcoma) that have come back after standard treatments. Doctors will collect a patient's own immune cells, genetically modify them in a lab to recognize and a…

This early-stage study is testing a new type of CAR-T cell therapy designed to be simpler and potentially cheaper. It aims to treat adults and teens with B-cell leukemia or lymphoma that has returned or not responded to standard treatments. Instead of modifying a patient's cells …

This early-stage study aims to test the safety and early effectiveness of an investigational drug called BT02 for adults with blood cancers that have returned or not responded to previous treatments. Participants will receive BT02 through an IV every few weeks for up to two years…

This is an early safety study testing a new type of cell therapy for adults with B-cell blood cancers that have returned or not responded to standard treatments. The therapy, called 19UCART, uses genetically modified immune cells from a donor (not the patient) to target and kill …

This is a first-in-human study to test the safety and early effectiveness of a new personalized immunotherapy. It is for adults with certain advanced blood cancers (like Hodgkin lymphoma and others) that have a marker called CD30 and have come back or not responded to at least tw…

This study aims to collect detailed information from 1000 people with lymphoma to understand how different treatments work in real-world settings. Researchers will track patients' treatment plans, disease characteristics, and long-term health outcomes. The goal is to use this inf…

This study aims to understand how disorders in blood cell production are connected to various inflammatory and autoimmune diseases. Researchers will observe 5,000 adult patients who have these conditions, collecting their health information over time. The goal is to create a deta…

This study aims to create and test a structured follow-up system for children and young adults who have survived blood cancers like leukemia and lymphoma. It will track 400 survivors for three years to understand the long-term health problems they face and see if a new, organized…

This study aims to understand why strength training improves the health of people with various cancers. Researchers will enroll 150 patients with lung, breast, colon, blood, or lymph node cancers. Half will do supervised strength training twice a week for 12 weeks, while the othe…

This study aims to better understand the patterns seen on PET-CT scans in older adults (age 60+) with lymphoma. Researchers will analyze scans from about 63 patients to see if specific scan features can help doctors diagnose the disease more accurately and predict outcomes. The g…